Centuple Global Ltd

AI
Centuple Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Centuple Global Ltd

₹ 37.1 3.35%
23 Oct - close price
rubramed.com BSE: 531099
About

Incorporated in 1991, Checkpoint Trends Ltd is in the business of trading and consultancy[1]

Key Points

Business Overview:[1]
CTL (Formerly Rubra Medicaments Ltd) was engaged in the manufacture and sale of pharmaceutical formulations based in Hyderabad. The company is currently in the business of trading and providing different kinds of consulting services in India to all categories of clients.

Website BSE
  • Market Cap ₹ 20.3 Cr.
  • Current Price ₹ 37.1
  • High / Low ₹ 144 / 28.4
  • Stock P/E 16.5
  • Book Value ₹ 42.5
  • Dividend Yield 0.00 %
  • ROCE 15.0 %
  • ROE 12.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.87 times its book value
  • Company's median sales growth is 26.2% of last 10 years
  • Company's working capital requirements have reduced from 182 days to 14.7 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 12.3% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 215 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
0.20 0.29 0.17 0.47 0.10 0.05 0.10 0.25 11.71 108.59 174.09 279.41 0.00
0.25 0.03 0.11 0.71 0.07 0.08 0.14 0.16 11.62 106.79 173.32 279.78 0.18
Operating Profit -0.05 0.26 0.06 -0.24 0.03 -0.03 -0.04 0.09 0.09 1.80 0.77 -0.37 -0.18
OPM % -25.00% 89.66% 35.29% -51.06% 30.00% -60.00% -40.00% 36.00% 0.77% 1.66% 0.44% -0.13%
0.00 0.00 0.00 0.00 0.00 0.00 0.02 -0.02 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -0.05 0.26 0.06 -0.24 0.03 -0.03 -0.02 0.07 0.09 1.80 0.77 -0.37 -0.18
Tax % 0.00% 0.00% 0.00% -4.17% 0.00% 33.33% 0.00% 0.00% 0.00% 26.11% 25.97% 27.03% 0.00%
-0.05 0.26 0.06 -0.23 0.02 -0.04 -0.02 0.06 0.09 1.32 0.57 -0.48 -0.18
EPS in Rs -0.09 0.48 0.11 -0.42 0.04 -0.07 -0.04 0.11 0.16 2.41 1.04 -0.88 -0.33
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
0 0 0 2 1 1 0 2 1 1 0 574 562
0 0 0 2 1 1 0 2 1 1 0 572 560
Operating Profit -0 -0 0 -0 -0 0 0 -0 -0 0 0 2 2
OPM % -5% 10% -1.3% -31% 2.0% 2.0% -1.0% -7% 2.6% 20% 0.4% 0.4%
-3 0 0 -0 0 0 0 0 0 0 -0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax -3 -0 0 -0 -0 0 0 -0 -0 0 0 2 2
Tax % 0% 0% 0% 0% 0% 20% 0% 50% 0% -50% 40% 34%
-3 -0 0 -0 -0 0 0 -0 -0 0 0 2 1
EPS in Rs -5.61 -0.02 0.05 -0.29 -0.02 0.05 0.02 -0.07 -0.15 0.05 0.05 2.76 2.24
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 122%
5 Years: 311%
3 Years: 691%
TTM: 4542%
Compounded Profit Growth
10 Years: 65%
5 Years: 173%
3 Years: 175%
TTM: 1267%
Stock Price CAGR
10 Years: %
5 Years: 64%
3 Years: 92%
1 Year: -40%
Return on Equity
10 Years: 9%
5 Years: 10%
3 Years: 12%
Last Year: 13%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 5 5 5 5 5 5 5 5 5 5 5 5
Reserves -5 -5 -5 -5 -5 -5 -5 -5 -5 -5 -5 18
0 0 0 0 0 0 0 0 0 0 0 7
0 0 0 0 0 0 0 0 0 0 0 313
Total Liabilities 0 0 1 1 1 1 1 1 1 1 1 343
0 0 0 0 0 0 0 0 0 0 0 0
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
0 0 1 1 1 1 1 1 1 1 1 343
Total Assets 0 0 1 1 1 1 1 1 1 1 1 343

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0 -0 0 0 -0 0 1 -0 0 0 0 -28
0 0 0 0 0 0 0 0 0 -0 -0 0
-0 -0 0 0 -0 -0 0 0 0 0 0 28
Net Cash Flow -0 -0 0 0 -0 -0 1 -0 0 -0 0 0
Free Cash Flow -0 -0 0 0 -0 0 1 -0 0 -0 0 -28
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 114% 100% 133% -600% 17% 650% 5,200% 2,450% -12% 0% 190% -1,223%

Ratios

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 36 24 54 179 107 164 122 135 229 212 215
Inventory Days 0 0 0 0 0 0 0 1
Days Payable 197
Cash Conversion Cycle 36 24 54 179 107 164 122 135 229 212 19
Working Capital Days 18 -35 36 260 221 60 98 129 145 387 15
ROCE % -3% -3% 7% 25% -31% 3% 2% -3% -13% 3% 17% 15%

Insights

In beta
Mar 2024 Mar 2025 Mar 2026
Number of permanent employees on rolls
employees

Log in to view insights

Please log in to see hidden values.

Login

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

6 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
0.00% 0.00% 0.00% 0.00% 0.00% 10.85% 10.86% 10.86% 10.71% 8.59% 11.15% 19.14%
100.00% 100.00% 100.00% 99.99% 100.00% 89.14% 89.15% 89.14% 89.29% 91.40% 88.85% 80.85%
No. of Shareholders 1,7221,9812,0392,0732,1232,2042,2772,4162,3962,4572,4302,401

Documents

Announcements

Annual reports